Assessing Clinical Trial Experiences of Patients With Osteosarcoma

N/ANot Yet RecruitingNCT05535283

Power Life Sciences Inc.500 enrolled

Overview

Clinical study participation has historically been heavily biased toward specific demographics. Several people will be invited to enroll in this study so that it may collect a variety of data about osteosarcoma clinical trial experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal. People with osteosarcoma who are invited to take part in medical research will benefit from the analysis of the data.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Osteosarcoma

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient has been diagnosed with osteosarcoma * Patient has self-identified as planning to enroll in an interventional clinical trial * Patient is a minimum of 18 years or older Exclusion Criteria: * ECOG score of 4 * Patient is pregnant * Inability to perform regular electronic reporting * Patient does not understand, sign, and return consent form

Outcomes

Primary Outcomes

Number of patients who decide to enroll in an osteosarcoma clinical trial

Time frame: 3 months

Rate of patients who remain in osteosarcoma clinical trial to trial completion

Time frame: 12 months

Central Contacts

Michael B Gill

CONTACT

4159004227 bask@withpower.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.